Jothydev's Diabetes Research Centre is the first ISO certified and the International Diabetes Federation recognized comprehensive diabetes care centre in Kerala, India since 1997. The centre is dedicated to customized intensive diabetes management with patients from across the globe and offers entire diabetes preventive care packages under one roof. It is also the first diabetes care centre with more than two decades of experience treating diabetes via the telemedicine-based management platform.
Since its initiation, the centre has been in the forefront delivering effective diabetes management technologies, therapies and research which is an exclusive indulgence of recent advancements in diabetes.
International Journal of Diabetes and Technology (IJDT), the flagship journal of Jothydev's Diabetes and Research Centre, is the first International journal from India publishing the finest quality peer reviewed articles on wide spectrum of technologies together with all the aspects of diabetes including types, pathogenesis, diagnosis, treatments, therapeutics, comorbidities, case reports and diabetes management technologies such as glucose meters, continuous monitoring devices, insulin pens, mobile apps, pumps, Artificial pancreas and telemedicine for diabetes care. IJDT joins the endeavors of similar publications that venture to improve the consensus of researchers, practitioners, and other stakeholders of diabetes care, on the applicability of technological innovations in effective diabetes care management.
The significance of technologies in diabetes management is becoming ever more relevant as it aids practitioners to facilitate improved decision-making and deliver better care. The journal has an Editorial Board with exclusive representation of key opinion leaders across the globe.
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
International Journal of Diabetes and Technology is a tri-monthly, peer-reviewed scientific e-journal published by Wolters Kluwer that publishes Original Articles, Review Articles, Commentary Articles, Analysis Articles, Letters to the Editor, scientific and medical literature focusing on diverse areas of diabetes and diabetes management technologies and therapies.
IJDT encourages articles on the following areas:
- Diabetes: all types
- Diabetes technologies â€“ Glucose meters, Continuous monitoring devices, Insulin pens, Insulin pumps, Artificial pancreas, Connected insulin pens etc.
- Diabetes treatment and therapeutics
- Innovations and advancements in diabetes management and care
- AI and machine learning in glucose sensing
- Electronic Medical Records
- Clinical trials
- Case reports
List of specialties the journals deal with:
- Diabetes and allied specialties